mosquito-borne diseases vaccine

NIH Begins Study of Vaccine to Protect Against Mosquito-Borne Diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial to test an investigational vaccine intended to provide broad protection against a range of mosquito-transmitted diseases, such as Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit such infections.

Read More



sepsis in the ICU

Study Results of Intensix Platform in Predicting Sepsis in the ICU

Intensix, developer of a real-time predictive analytics platform for early detection of patient deterioration in the ICU and high acuity departments of hospitals, has announced the positive results of a clinical study of the effectiveness of the Intensix platform in detecting and predicting sepsis in the ICU.